A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
- Status
- UNKNOWN
- Phase
- NA
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1